Showing posts with label Big data. Show all posts
Showing posts with label Big data. Show all posts

Monday, 13 June 2022

Digital transformation as a new determinant of health

Elena Torrente
 



The Spanish Ministry of Health has recently published the Digital Health Strategy of the National Health System. The document, closely aligned with the WHO and European Union strategy on this matter, presents three main lines of action:

  1. Development of digital health services aimed at people, organizations and processes that make up the health protection system, with an equity approach.
  2. Generalization to the maximum of the interoperability of health information.
  3. Promotion of the analysis of data related to health, its determinants and the health system.

Monday, 27 July 2020

With Amazon, there is no going back

Paco Miralles





A winter desert. The author discusses his post with friends: "The future of medicine is changing daily, but the point of no return will be when Amazon enters the healthcare market ..."

I noticed the smile on my friends' faces when I made these comments to them. I do not have enough scientific relevance to lavish myself in informative talks, so my remarks were in opinions of the same level as those referring to what Atletico will do if it does not qualify for the Champions League. They thought it was an exaggeration and that the medicine was indeed changing a lot, but no so much.

Monday, 10 June 2019

Cancer research: little science, big data or big science







Apparently, the duration and costs of clinical trials of new oncological drugs could be reduced if surrogate measures, such as tumour reduction or time to progression, were to be used instead of survival, but a meta-analysis of 146 clinical trials of colorectal cancer and 191 of lung cancer found that only 10-16% of survival was explained by these variables; obviously a poor correlation. On the other hand, there is the question of the methodology used. A review of 43 studies found that, in 81% of the cases, promising results from phase II (without a control group) failed to transfer to phase III (double-blind randomized trial). The latter is another finding unfavourable to the rush with which many oncological drugs are introduced in the market. Perhaps it’s for this reason that, in an observation of 94 articles on the subject, Abola and Prasad have discovered that in half of them, the editors had resorted to adjectives of the type: miraculous, revolutionary, innovative, wonderful, transformative, etc...

Monday, 25 June 2018

The red line of health data

Elena Torrente




The great technological giants (Google, Apple, IBM or Microsoft) are recruiting scientists and experts in medical research. Their commitment to transform medicine is decided, but John T. Wilbanks and Eric J. Topol warn of possible risks in this interesting article published in Nature. Given the difficulties that medical research has always encountered in obtaining health data, the authors believe that it may be tempting for clinical scientists to access large-scale Internet projects, with significant data collection capabilities and algorithms for analysis.

But there is a risk that Google or other smaller companies such as 23andMe, will access health data with the aim of controlling the methods used to offer certain services based on digital profiles. This is what in other sectors of the Internet is called the society of the "black box". There are ads that are only offered to certain groups of people and if these algorithms incorporate health data, the authors say that pre-existing biases in our society would increase along with inequalities.

Monday, 30 November 2015

Personal health data: a new treasure for science








At seeing a survey by the Institute of Medicine (IOM) one fact stands out: 94% of Americans who are diagnosed with a chronic disease and are also social network users would be willing to donate their data to encourage research thus helping other patients like them.

In this context, the website "PatientsLikeMe", the most developed patients social network in the world, has launched a campaign to encourage the donation of data, so I invite you to see this promotional video: "Your data has a heartbeat that gives life to medical research.”